EN
HI
Summary
As of 16 Nov, 2026, Aarti Pharmalabs stock price is ₹997.95. During the trading session, the stock has moved between an intraday low of ₹989.70 and an intraday high of ₹1019.50. Over the last 52 weeks, Aarti Pharmalabs has traded between ₹585.00 and ₹1019.50.
The stock has recorded a trading volume of 6,15,922 shares,. Its Average Traded Price (ATP) is ₹1004.45, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹997.95.
Aarti Pharmalabs has an upper circuit limit of ₹1197.50 and a lower circuit limit of ₹798.40. The total value traded stands at ₹61.87 CR, and the delivery percentage for the day is 31.35%.
The stock is currently traded with a market lot size of 1. Aarti Pharmalabs also offers a dividend yield of 0.35%.
Aarti Pharmalabs Share Price Chart
Aarti Pharmalabs Share Key Metrics
Volume
6.16 L
Market Cap
9049.39 CR
LTQ@LTP
1@997.95
ATP
1004.45
Var Margin
23.09 %
Circuit Range
798.4-1197.5
Delivery %
31.35 %
Value
61.87 CR
ASM/GSM
No
Market Lot
1
Aarti Pharmalabs Fundamentals
P/E Ratio
35.3
P/B Ratio
4.02
Div. Yield
0.35
Sector P/E
41.18
Sector P/B
2.49
Sec. Div. Yield
0.53
Aarti Pharmalabs Resistance and Support
Pivot 984.77
Resistance
First Resistance
1044.74
Second Resistance
1078.97
Third Resistance
1138.94
Support
First Support
950.54
Second Support
890.57
Third Support
856.34
Aarti Pharmalabs Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Nov 13 2026 | 1015 | 997.95 | -1.24% | 1019.5 | 989.7 |
| Thu Nov 12 2026 | 929 | 1010.5 | 9.42% | 1019 | 924.79 |
| Wed Nov 11 2026 | 936 | 923.5 | 0.23% | 941.84 | 920.04 |
Aarti Pharmalabs Corporate Actions
| Date | Agenda |
|---|---|
| 2026-10-28 | Quarterly Results |
| 2026-08-07 | Quarterly Results |
| 2026-05-25 | Audited Results & Final Dividend |
| 2026-05-18 | Audited Results & Final Dividend |
| 2026-02-09 | Quarterly Results & Interim Dividend |
| 2025-11-09 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-10 | Audited Results & Final Dividend |
| 2025-02-05 | Quarterly Results |
| 2024-10-28 | Quarterly Results |
| 2024-08-05 | Quarterly Results |
Aarti Pharmalabs News
Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Demise
Aarti Pharma Labs announced the demise of its Chairman Emeritus and Promoter, Shri Chandrakant Vallabhaji Gogri, on November 15, 2026. Consequently, he ceases to be classified as a promoter of the company.
Nov 15 2026 23:13:12
Aarti Pharmalabs Ltd - 543748 - Board Meeting Outcome for Outcome Of Board Meeting Held On October 28, 2026
Aarti Pharma reported Q2 FY27 cons. revenue of ₹610.45 crore (up 46% YoY) and a net profit of ₹71.47 crore (up 248% YoY). In a leadership transition, the company appointed Vibha Thakkar as the new CFO, succeeding Piyush Lakhani who resigned to pursue alternate opportunities.
Oct 28 2026 20:55:17
Aarti Pharmalabs Management
| Name | Position |
|---|---|
| Jeevan Mondkar | Company Secretary |
| Chandrakant V Gogri | Chairman Emeritus |
Aarti Pharmalabs Similar Stocks
Jupiter Life Line Hospitals Ltd.
284.80
-2.00 (0.70%)
Strides Pharma Science Ltd.
1014.60
5.30 (0.53%)
Paras Healthcare Ltd.
936.30
54.10 (6.13%)
Procter & Gamble Health Ltd.
5809.00
0.00 (0.00%)
Healthcare Global Enterprises Ltd.
572.95
-2.80 (0.49%)
Suven Life Sciences Ltd.
277.80
-3.85 (1.37%)
Thyrocare Technologies Ltd.
498.25
10.25 (2.10%)
Sanofi India Ltd.
3301.40
20.50 (0.62%)
Bliss GVS Pharma Ltd.
673.10
31.55 (4.92%)
Kovai Medical Center & Hospital Ltd.
6562.00
32.50 (0.50%)
Aarti Pharmalabs FAQs
The Buying Price of Aarti Pharmalabs share is 997.95 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Aarti Pharmalabs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Aarti Pharmalabs, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Aarti Pharmalabs shares is 35.3. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Aarti Pharmalabs shares is 4.02. Useful to assess the stock's value relative to its book value.
To assess Aarti Pharmalabs’s valuation compare Sector P/E, P/B which are 41.18 & 2.49 with sector averages, along with growth rates and financial metrics.
The Market Cap of Aarti Pharmalabs is 9049.39 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Aarti Pharmalabs share price is 1019.50 & 585.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Aarti Pharmalabs belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in AARTIPHARM
Or Download Choice FinX App
Invest in AARTIPHARM
